SPARK team receives Award “Paper-of the Quarter” by German Society for Gene Therapy e.V.

The Goal of Jonas Kath’s and Dimitrios Wagner’s SPARK project is to develop a virus-free platform technology for the generation of novel improved and cost-effective CAR-therapeutics that are suitable for autologous and/or allogenic use.

The technology has been recently published in Blood (PUBLICATION) and now received the “Paper of the Quarter” award by the German Society for Gene Therapies. 

SPARK-BIH congratulates the team for their achievements and wishes continuous success in the implementation of their research to the clinic.

SPARK-BIH is a member of the SPARK Global network